Skip to main content
. 2022 Apr 26;12(5):694. doi: 10.3390/jpm12050694

Figure 4.

Figure 4

SARS-CoV-2-specific T-cellular reactivity (in%) of IBD patients and healthy controls six months after the second vaccination. Subdivision into positive T-cellular reactivity and marginally positive T cellular reactivity. ns, not significant. Categorical variables were compared using the chi-square test or Fisher’s exact test.